The independent source for health policy research, polling, and news.
721 - 740 of 1,380 Results
The market is flooded with 28 different medications for just 20,000 patients with the hereditary bleeding disorder. Yet intense competition hasn’t worked to bring costs down. Sales amount to $4.6 billion annually in the U.S.
Medicaid payments allow struggling hospitals to maintain vital costly services such as maternity care.
The state branded its Medicaid expansion with some key conservative policies, and officials and advocates across the country are keenly watching the results.
As more Americans are diagnosed with dementia, families who have firearms struggle with ways to stay safe. A KHN investigation uncovered dozens of cases of deaths and injuries.
SuperAgers, men and women over age 80 with extraordinary memories, share a commitment to sustaining friendships.
An addiction-treatment physician fatally shot a troubled ex-Marine after the man pummeled him inside his California office, police records show. The tragedy illustrates how the limited number of clinics available to prescribe buprenorphine, a drug that all but erases opioid withdrawal, can become crowded, chaotic and dangerous.
In Louisiana, the wining and dining of lawmakers by scores of pharma lobbyists proves a valuable lesson on how to win statehouse votes and influence profits.
The program will also set monthly premiums for Medicaid coverage and penalties for those who don’t make the payments.
Proponents say the proposed regulation will give some consumers more affordable insurance options. Critics warn that the coverage could be less comprehensive.
Studies show promising results for a treatment approach that tackles chronic pain and addiction together, but obstacles stand in the way of this integrated care.
The FDA’s Scott Gottlieb says the agency is focused on the big picture, and he wants to know why pharma churns out drugs for some rare diseases but not for others.
Medicines are up to 80 percent cheaper north of the border and overseas, so U.S. localities are greasing a pharmaceutical pipeline that the feds warn is illegal and possibly unsafe.
Fewer than half of health care workers at a nonprofit Florida hospice had completed advance directives for end-of-life care.
The House and Senate want to reduce or eliminate federal tax credits for “orphan drugs” used to treat rare diseases, but patients are fighting against the plan.
Premature death, a dearth of treatments, mistreatment in emergency rooms and a woeful lack of funding are just a few of the problems confronting people with sickle cell disease.
Medicare and insurers struggle to oversee a booming business in testing urine samples. In some cases, pain doctors’ lack of follow-through can turn fatal.
A handful of Silicon Valley start-ups are trying to usher medical billing into the 21st century by creating smartphone apps to help consumers navigate their health insurance paperwork.
An explosive report prepared by a SynerMed executive alleges the California firm, which oversaw care for 1.2 million patients, fabricated documents and violated state and federal regulations for years. The state says it left low-income patients on Medicaid managed care in “imminent danger.”
This year’s Obamacare open enrollment will be marked by a number of changes. KHN helps you navigate them.
ICU nurse Julayne Smithson had only a few minutes to grab some things from her recently purchased home a block from the Santa Rosa hospital. Then she rushed back to help evacuate patients and has scarcely stopped working since.
© 2026 KFF